Marksans Pharma receives upgrade in credit ratings

From India Ratings and Research
Marksans Pharma announced that India Ratings & Research has upgraded the company's long term issuer rating to IND A/ Positive from IND A-. The instrument-wise rating action are as under:
Fund based bank facilities - IND A/ Positive (rating upgraded)
Non fund based bank facilities - IND A1 (ratings affirmed)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 30 2021 | 2:00 PM IST
